Patent 7705049 was granted and assigned to New York University on April, 2010 by the United States Patent and Trademark Office.
The present invention relates to a method for treating non-melanotic cancers by administration of PABA. The present invention also relates to the potentiation of standard cancer treatment of radiation, radioimmunotherapy, and/or chemotherapy using PABA.